腸管管理システムの世界市場予測（2022年～2027年）

世界の腸管管理システムの市場規模は、2020年に7億4,815万2,000米ドルとなり、予測期間中に4.04％のCAGRで成長し、2027年に9億8,730万1,000米ドルになると予測されています。市場を牽引する要因には、腸疾患の増加や老年人口の増加に伴う腸管管理システムの採用などが挙げられます。

当レポートでは、世界の腸管管理システム市場について調査し、市場規模や予測、COVID-19の影響、市場の促進要因および課題、市場動向、セグメント別の市場分析、競合情勢、主要企業のプロファイルなどの体系的な情報を提供しています。

目次

第1章 イントロダクション

• 市場概要
• COVID-19の影響
• 市場の定義
• 市場セグメンテーション

第2章 調査手法

• 調査データ
• 前提条件

第3章 エグゼクティブサマリー

• 調査のハイライト

第4章 市場力学

• 市場促進要因
• 市場抑制要因
• ポーターのファイブフォース分析
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• 業界のバリューチェーン分析

第5章 世界の腸管管理システム市場分析：製品別

• イントロダクション
• 人工肛門バッグ
• イリゲーションシステム
• 神経調節装置
• その他

第6章 世界の腸管管理システム市場分析：患者タイプ別

• イントロダクション
• 成人
• 小児

第7章 世界の腸管管理システム市場分析：エンドユーザー別

• イントロダクション
• 病院
• 外来センター
• 在宅医療

第8章 世界の腸管管理システム市場分析：地域別

• イントロダクション
• 北米
  • 米国
  • カナダ
  • メキシコ
• 南米
  • ブラジル
  • アルゼンチン
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • スペイン
  • その他
• 中東・アフリカ
  • サウジアラビア
  • イスラエル
  • その他
• アジア太平洋地域
  • 中国
  • 日本
  • 韓国
  • インド
  • タイ
  • 台湾
  • インドネシア
  • その他

第9章 競合環境と分析

• 主要企業と戦略分析
• 新興企業と市場の有利性
• 合併、買収、契約、コラボレーション
• ベンダーの競合マトリックス

第10章 企業プロファイル

• Cogentix Medical
• Hollister Incorporated
• Mbh-International A/S
• Mederi Therapeutics Inc
• B. Braun
• Aquaflush Medical Limited
• Consure
• Wellsspect health care
• ConvaTec Group Plc.
• ProSys International Ltd.

The global bowel management systems market is projected to grow at a CAGR of 4.04% to reach US$987.301 million by 2027, from US$748.152 million in 2020.

The increasing number of bowel diseases and the rising geriatric population are causing end-users to adopt bowel management systems.

The bowel management system is used for the management of faecal inconsistency in patients and helps them keep their skin free from contaminants and infections. The device is a soft catheter that is inserted into the rectum to contain and divert faecal waste. The surge in availability of technologically advanced devices for fecal management, the rise in the geriatric population, and the increase in fecal inconsistency-related disorders are the major factors that are driving the market for bowel management systems to grow Furthermore, increased awareness of the availability of these devices, combined with the introduction of new devices that address many unserved needs contributes to the bowel management system market's growth.

According to the International Foundation of Gastrointestinal Disorders (IFFGD), around 10-15% of the global population has irritable bowel syndrome (IBS). Furthermore, favourable reimbursement scenarios in developed economies, as well as technological advancements in bowel management systems, are driving the market growth.

Some products that are offered are:

• Bioness, Inc., one of the leading providers of advanced and clinically supported medical devices for the treatment of pain originating in the peripheral nerves, announced that its product, the "StimRouter® Neuromodulation System," has been approved by the FDA and has received the CE mark for approval in order to facilitate the treatment of fecal incontinence (also known as bowel incontinence). This product is available throughout Europe and allows physicians to treat patients with faecal or bowel incontinence by inserting a small implant into the tibial nerve near the ankle. In addition, this product is minimally invasive and easier to implant near the nerve Tibialis.
• BD, which is considered among the leading medical equipment and solutions companies globally, offers their product called the "BARD DIGNISHEILD Stool Management System". This product is able to effectively mitigate the damage that is caused to delicate tissues due to any leakage, pressure, or friction. It also aids the patient by protecting them from exposure, tissue damage, and odour. The system offered by the company consists of a catheter tube assembly, a 60cc syringe, a collection bag, and a jelly used to lubricate the syringe. In addition, other products such as an odour eliminator and a tube clam are also included.
• B. Braun Melsungen AG, one of the leading medical product manufacturing and proving companies globally offers a range of products under its Fecal Incontinence & Bowel Management segment, which includes a Rectobag and a Rectal Catheter. The Rectobag is a closed system that is used to facilitate repeated intestinal salvage and diagnostics. It is made up of a conical connector, a bore transfer tube with a 7.5 mm diameter and a length of 10 cm with a closing clamp. It also has a liquid and odour-tight inlet as well as eyelets with a strong suspension. The Irrigation Catheter, also known as a rectal catheter, has a colour-coded cone fitting, a closed rounded tip, and two laterally positioned eyes.

A colostomy is estimated to hold a sizable share over the forecast period owing to the high prevalence of bowel health complications

Over the forecast period, colostomy bags are estimated to hold a significant share, which is attributed to the fact that the number of individuals suffering from diseases and complications associated with the bowel is increasing. In addition, diseases such as irritable bowel syndrome are getting more common among older individuals. According to the Centers for Disease Control and Prevention, approximately 1.3 million people have inflammatory bowel syndrome.

The problem of faecal inconsistency is more prevalent among adults.

The loss of cognitive function and the decrease in alertness and control over bloody functions becomes more prevalent as individual ages, and this is one of the reasons why geriatric individuals require assistance. The majority of adults have faecal incontinence. As a result, this factor is driving up demand for bowel management systems.

The North American region is estimated to hold a noteworthy market share growth over the forecast period owing to the rising number of serious diseases, well-positioned healthcare facilities, and well-developed healthcare infrastructure. In addition, the rising awareness among patients regarding the risk of various bowel problems is also expected to contribute to the market share of this region. Due to an increase in the number of serious diseases such as intestinal cancer and colorectal cancer among the population, the North American region is expected to hold significant market share growth over the forecast period. As a result, the risk of various bowel diseases affecting the geriatric population is increasing.

Recent Developments

• ConfiPlus, a large doughnut-shaped device suitable for a colostomy, ileostomy, or urostomy, was invented by Anne Inch in Scotland in August 2021. If a leak happens, the material draws it into the foam. It gives the user time to change before anything gets into their clothes. This device has changed the lives of both patients and healthcare providers.
• USMIMA S.L. announced in December 2021 that the USFDA had granted the breakthrough device designation to its first product, the "MOWOOT II Intestinal Transit Management System". The device provides a novel, purely physical, non-drug, and non-invasive treatment for patients suffering from intestinal transit disorders such as chronic constipation. It enables more effective and efficient management of neurogenic bowel disorder (NBD), a severe form of chronic constipation.
• The FDA approved Medtronic's InterStim Micro neurostimulator and InterStim SureScan MRI for the treatment of patients with bladder and bowl control conditions in August 2020. This invention will help them gain a competitive advantage over their competitors.

COVID-19 impact on Bowel Management Systems Market

The pandemic of COVID-19 had a negative impact on the global market for bowel management systems. As a result of the COVID-19 outbreak, which resulted in strict border controls, stock market instability, and country-wide lockdowns, this pandemic hampered the manufacture and delivery of bowel management systems. Lockdowns in many countries during the early stages of the pandemic hampered the production of bowel management systems. All of these changes are had a negative impact on the bowel management system market, prompting industry and regulators to reconsider supply chains.

Bowel Management Systems Market Scope:

Report Metric Details

Market Size Value in 2020 US$748.152 million

Market Size Value in 2027 US$987.301 million

Growth Rate CAGR of 4.04% from 2020 to 2027

Base Year 2020

Forecast Period 2022-2027

Forecast Unit (Value) USD Million

Segments Covered Product, Patient Type, End-User, And Geography

Regions Covered North America, South America, Europe, Middle East and Africa, Asia Pacific

Companies Covered Cogentix Medical, Hollister Incorporated, Mbh-International A/S, Mederi Therapeutics Inc, B. Braun Melsungen AG, Aquaflush Medical Limited, Consure, Wellspect health care, ConvaTec Group Plc., ProSys International Ltd.

Customization Scope Free additonal report customization

Market Segmentation:

• By Product

Colostomy Bags

Irrigation Systems

Nerve Modulation Devices

Others

• By Patient Type

Adults

Paediatric

• By End-User

Hospitals

Ambulatory Centers

Home Care

• By Geography

North America

• USA
• Canada
• Mexico

South America

• Brazil
• Argentina
• Others

Europe

• Germany
• France
• United Kingdom
• Spain
• Others

Middle East and Africa

• Saudi Arabia
• Israel
• Others

Asia Pacific

• China
• Japan
• South Korea
• India
• Thailand
• Taiwan
• Indonesia
• Others

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Overview
• 1.2. COVID-19 Impact
• 1.3. Market Definition
• 1.4. Market Segmentation

2. Research Methodology

• 2.1. Research Data
• 2.2. Assumptions

3. Executive Summary

• 3.1. Research Highlights

4. Market Dynamics

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. Global Bowel Management Systems Market Analysis, By Product

• 5.1. Introduction
• 5.2. Colostomy Bags
• 5.3. Irrigation Systems
• 5.4. Nerve Modulation Devices
• 5.5. Others

6. Global Bowel Management Systems Market Analysis, By Patient Type

• 6.1. Introduction
• 6.2. Adults
• 6.3. Paediatric

7. Global Bowel Management Systems Market Analysis, By End-User

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Ambulatory Centers
• 7.4. Home Care

8. Global Bowel Management Systems Market Analysis, By Geography

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. Israel
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. Japan
  • 8.6.3. South Korea
  • 8.6.4. India
  • 8.6.5. Thailand
  • 8.6.6. Taiwan
  • 8.6.7. Indonesia
  • 8.6.8. Others

9. Competitive Environment and Analysis

• 9.1. Major Players and Strategy Analysis
• 9.2. Emerging Players and Market Lucrativeness
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Vendor Competitiveness Matrix

10. Company Profiles

• 10.1. Cogentix Medical
• 10.2. Hollister Incorporated
• 10.3. Mbh-International A/S
• 10.4. Mederi Therapeutics Inc
• 10.5. B. Braun
• 10.6. Aquaflush Medical Limited
• 10.7. Consure
• 10.8. Wellsspect health care
• 10.9. ConvaTec Group Plc.
• 10.10. ProSys International Ltd.